Dermatopolymyosite et cancer: étude rétrospective de 12 cas parmi une cohorte de 50. Évolution et facteurs prédictifs
R Cozac Batut, P. Arlet(Centre de Référence Déficits Immunitaires Héréditaires), H. Juchet(Hôpital Rangueil), M. Tubéry, C. Dingremont(Hôpital Rangueil), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 3
Related Papers
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
|Nature Medicine|2024|109
Acute interstitial nephritis related to immune checkpoint inhibitors
|British Journal of Cancer|2016|103